{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:43:30Z","timestamp":1793241810363,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11910-020-01076-w","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T02:02:42Z","timestamp":1601258562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Recent Advances in Blood-Based Biomarkers of Remote Combat-Related Traumatic Brain Injury"],"prefix":"10.1007","volume":"20","author":[{"given":"Sara M.","family":"Lippa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kent","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Diaz-Arrastia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8138-7539","authenticated-orcid":false,"given":"Kimbra","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,28]]},"reference":[{"key":"1076_CR1","unstructured":"Defense and Veterans Brain Injury Center (DVBIC). http:\/\/www.dvbic.org\/TBI-Numbers.aspx. 2019."},{"key":"1076_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6609a1","volume":"66","author":"CA Taylor","year":"2017","unstructured":"Taylor CA, Bell JM, Breiding MJ, Xu L. Traumatic brain injury-related emergency department visits, hospitalizations, and deaths - United States, 2007 and 2013. MMWR Surveill Summ. 2017;66:1\u201316. https:\/\/doi.org\/10.15585\/mmwr.ss6609a1.","journal-title":"MMWR Surveill Summ"},{"key":"1076_CR3","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/TA.0b013e31816093bd","volume":"64","author":"PR Cordts","year":"2008","unstructured":"Cordts PR, Brosch LA, Holcomb JB. Now and then: combat casualty care policies for Operation Iraqi Freedom and Operation Enduring Freedom compared with those of Vietnam. J Trauma. 2008;64:S14\u201320; discussion S. https:\/\/doi.org\/10.1097\/TA.0b013e31816093bd.","journal-title":"J Trauma"},{"key":"1076_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1176\/jnp.10.3.308","volume":"10","author":"DL Trudeau","year":"1998","unstructured":"Trudeau DL, Anderson J, Hansen LM, Shagalov DN, Schmoller J, Nugent S, et al. Findings of mild traumatic brain injury in combat veterans with PTSD and a history of blast concussion. J Neuropsychiatry Clin Neurosci. 1998;10:308\u201313. https:\/\/doi.org\/10.1176\/jnp.10.3.308.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1076_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fneur.2019.00446","volume":"10","author":"ZS Gan","year":"2019","unstructured":"Gan ZS, Stein SC, Swanson R, Guan S, Garcia L, Mehta D, et al. Blood biomarkers for traumatic brain injury: a quantitative assessment of diagnostic and prognostic accuracy. Front Neurol. 2019;10:446. https:\/\/doi.org\/10.3389\/fneur.2019.00446.","journal-title":"Front Neurol."},{"key":"1076_CR6","first-page":"411","volume-title":"Textbook of clinical neuropsychology","author":"HG Belanger","year":"2018","unstructured":"Belanger HG, Tate DF, Vanderploeg RD. Concussion and mild traumatic brain injury. In: Morgan JE, Ricker JH, editors. Textbook of clinical neuropsychology. 2nd ed. New York: Routledge; 2018. p. 411\u201348.","edition":"2"},{"key":"1076_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3389\/fneur.2017.00300","volume":"8","author":"EP Thelin","year":"2017","unstructured":"Thelin EP, Zeiler FA, Ercole A, Mondello S, Buki A, Bellander BM, et al. Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: a systematic review. Front Neurol. 2017;8:300. https:\/\/doi.org\/10.3389\/fneur.2017.00300.","journal-title":"Front Neurol."},{"key":"1076_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev.pharmtox.41.1.347","volume":"41","author":"LJ Lesko","year":"2001","unstructured":"Lesko LJ, Atkinson AJ Jr. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol. 2001;41:347\u201366. https:\/\/doi.org\/10.1146\/annurev.pharmtox.41.1.347.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1076_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1373\/clinchem.2007.097360","volume":"54","author":"RR Packard","year":"2008","unstructured":"Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008;54:24\u201338. https:\/\/doi.org\/10.1373\/clinchem.2007.097360.","journal-title":"Clin Chem."},{"key":"1076_CR10","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jama.2016.2240","volume":"315","author":"MA Robb","year":"2016","unstructured":"Robb MA, McInnes PM, Califf RM. Biomarkers and surrogate endpoints: developing common terminology and definitions. JAMA. 2016;315:1107\u20138. https:\/\/doi.org\/10.1001\/jama.2016.2240.","journal-title":"JAMA."},{"key":"1076_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","volume":"5","author":"K Strimbu","year":"2010","unstructured":"Strimbu K, Tavel J. What are biomarkers? Curr Opin HIV AIDS. 2010;5:463\u20136.","journal-title":"Curr Opin HIV AIDS"},{"key":"1076_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","volume":"243","author":"RM Califf","year":"2018","unstructured":"\u2022 Califf RM. Biomarker definitions and their applications. Exp Biol Med (Maywood). 2018;243:213\u201321. https:\/\/doi.org\/10.1177\/1535370217750088Review article describing four types of biomarkers (diagnostic, prognostic, predictive and pharmacodynamic) and their applications.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1076_CR13","unstructured":"FDA Decision Memorandum. Evaluation of Automatic Class III Designation for Benyon Brain Trauma Indicator. 2018."},{"key":"1076_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/14737159.2018.1428089","volume":"18","author":"KK Wang","year":"2018","unstructured":"Wang KK, Yang Z, Zhu T, Shi Y, Rubenstein R, Tyndall JA, et al. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn. 2018;18:165\u201380. https:\/\/doi.org\/10.1080\/14737159.2018.1428089.","journal-title":"Expert Rev Mol Diagn."},{"key":"1076_CR15","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/TA.0b013e3182491e3d","volume":"72","author":"L Papa","year":"2012","unstructured":"Papa L, Lewis LM, Silvestri S, Falk JL, Giordano P, Brophy GM, et al. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J Trauma Acute Care Surg. 2012;72:1335\u201344. https:\/\/doi.org\/10.1097\/TA.0b013e3182491e3d.","journal-title":"J Trauma Acute Care Surg."},{"key":"1076_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/neu.2013.3040","volume":"31","author":"R Diaz-Arrastia","year":"2014","unstructured":"Diaz-Arrastia R, Wang KK, Papa L, Sorani MD, Yue JK, Puccio AM, et al. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma. 2014;31:19\u201325. https:\/\/doi.org\/10.1089\/neu.2013.3040.","journal-title":"J Neurotrauma."},{"key":"1076_CR17","doi-asserted-by":"publisher","first-page":"S478","DOI":"10.1097\/TA.0b013e318232fa70","volume":"71","author":"J Topolovec-Vranic","year":"2011","unstructured":"Topolovec-Vranic J, Pollmann-Mudryj M-A, Ouchterlony D, Klein D, Spence J, Romaschin A, et al. The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury. J Trauma. 2011;71:S478\u2013S86. https:\/\/doi.org\/10.1097\/TA.0b013e318232fa70.","journal-title":"J Trauma."},{"key":"1076_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1034\/j.1600-0404.2001.103003175.x","volume":"103","author":"JR de Kruijk","year":"2001","unstructured":"de Kruijk JR, Leffers P, Menheere PP, Meerhoff S, Twijnstra A. S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls. Acta Neurol Scand. 2001;103:175\u20139.","journal-title":"Acta Neurol Scand"},{"key":"1076_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/01.shk.0000168876.68154.43","volume":"24","author":"LE Pelinka","year":"2005","unstructured":"Pelinka LE, Hertz H, Mauritz W, Harada N, Jafarmadar M, Albrecht M, et al. Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings. Shock. 2005;24:119\u201323. https:\/\/doi.org\/10.1097\/01.shk.0000168876.68154.43.","journal-title":"Shock."},{"key":"1076_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2217\/bmm.10.111","volume":"4","author":"AL Teixeira","year":"2010","unstructured":"Teixeira AL, Barbosa IG, Diniz BS, Kummer A. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomarkers Med. 2010;4:871\u201387. https:\/\/doi.org\/10.2217\/bmm.10.111.","journal-title":"Biomarkers Med."},{"key":"1076_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/neu.2015.3949","volume":"33","author":"FK Korley","year":"2016","unstructured":"Korley FK, Diaz-Arrastia R, Wu AHB, Yue JK, Manley GT, Sair HI, et al. Circulating brain-derived neurotrophic factor has diagnostic and prognostic value in traumatic brain injury. J Neurotrauma. 2016;33:215\u201325. https:\/\/doi.org\/10.1089\/neu.2015.3949.","journal-title":"J Neurotrauma."},{"key":"1076_CR22","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/jts.22418","volume":"32","author":"CL Pattinson","year":"2019","unstructured":"\u2022\u2022 Pattinson CL, Gill JM, Lippa SM, Brickell TA, French LM, Lange RT. Concurrent mild traumatic brain injury and posttraumatic stress disorder is associated with elevated tau concentrations in peripheral blood plasma. J Trauma Stress. 2019;32:546\u201354. https:\/\/doi.org\/10.1002\/jts.22418Found that plasma tau levels were higher in service members\/veterans with mild TBI and who met screening criteria for PTSD, compared to controls and participants with history of mild TBI only but no PTSD.","journal-title":"J Trauma Stress"},{"key":"1076_CR23","doi-asserted-by":"publisher","first-page":"e2412","DOI":"10.1212\/WNL.0000000000009577","volume":"94","author":"VA Guedes","year":"2020","unstructured":"\u2022\u2022 Guedes VA, Kenney K, Shahim P, Qu BX, Lai C, Devoto C, et al. Exosomal neurofilament light: a prognostic biomarker for remote symptoms after mild traumatic brain injury? Neurol. 2020;94:e2412\u2013e23. https:\/\/doi.org\/10.1212\/WNL.0000000000009577Exosomal and plasama NfL were elevated in veterans with repetitive mTBIs and related to all symptoms assessed. These findings suggest plasma NfL does not necessarily improve as a biomarker when examined in exosomal vesicles.","journal-title":"Neurol"},{"key":"1076_CR24","doi-asserted-by":"publisher","unstructured":"\u2022 Dickstein DL, De Gasperi R, Gama Sosa MA, Perez-Garcia G, Short JA, Sosa H, et al. Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure. Mol Psychiatry. 2020. https:\/\/doi.org\/10.1038\/s41380-020-0674-zPlasma NfL was increased in Veterans with tau-positive PET scans compared to Veterans with tau-negative PET scans and controls.","DOI":"10.1038\/s41380-020-0674-z"},{"key":"1076_CR25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fnins.2019.01005","volume":"13","author":"CN Winston","year":"2019","unstructured":"Winston CN, Romero HK, Ellisman M, Nauss S, Julovich DA, Conger T, et al. Assessing neuronal and astrocyte derived exosomes from individuals with mild traumatic brain injury for markers of neurodegeneration and cytotoxic activity. Front Neurosci. 2019;13:1005. https:\/\/doi.org\/10.3389\/fnins.2019.01005.","journal-title":"Front Neurosci."},{"key":"1076_CR26","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1001\/jamaneurol.2015.1383","volume":"72","author":"A Olivera","year":"2015","unstructured":"Olivera A, Lejbman N, Jeromin A, French LM, Kim HS, Cashion A, et al. Peripheral total tau in military personnel who sustain traumatic brain injuries during deployment. JAMA Neurol. 2015;72:1109\u201316. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1383.","journal-title":"JAMA Neurol"},{"key":"1076_CR27","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1080\/02699052.2018.1483530","volume":"32","author":"K Kenney","year":"2018","unstructured":"\u2022\u2022 Kenney K, Qu BX, Lai C, Devoto C, Motamedi V, Walker WC, et al. Higher exosomal phosphorylated tau and total tau among veterans with combat-related repetitive chronic mild traumatic brain injury. Brain Inj. 2018;32:1276\u201384. https:\/\/doi.org\/10.1080\/02699052.2018.1483530Evaluated several plasma and exosomal biomarkers in veterans with TBI. Plasma and exosomal NfL were associated with repetitive mTBI and chronic symptoms.","journal-title":"Brain Inj"},{"key":"1076_CR28","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1089\/neu.2018.6269","volume":"36","author":"SM Lippa","year":"2019","unstructured":"\u2022\u2022 Lippa SM, Yeh PH, Gill J, French LM, Brickell TA, Lange RT. Plasma tau and amyloid are not reliably related to injury characteristics, neuropsychological performance, or white matter integrity in service members with a history of traumatic brain injury. J Neurotrauma. 2019;36:2190\u20139. https:\/\/doi.org\/10.1089\/neu.2018.6269Found no association of plasma tau and amyloid with injury characteristics, neuropsychological performance, diffusion tensor imaging, or posttraumatic stress symptoms in service members and veterans with TBI.","journal-title":"J Neurotrauma"},{"key":"1076_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/HTR.0000000000000485","volume":"35","author":"CL Pattinson","year":"2020","unstructured":"\u2022\u2022 Pattinson CL, Shahim P, Taylor P, Dunbar K, Guedes VA, Motamedi V, et al. Elevated tau in military personnel relates to chronic symptoms following traumatic brain injury. J Head Trauma Rehabil. 2020;35:66\u201373. https:\/\/doi.org\/10.1097\/HTR.0000000000000485Plasma tau was associated with postconcussion, post-traumatic stress, and depressive symptoms following TBI in military personnel. Plasma NfL was elevated in those with a history of repetitive TBI.","journal-title":"J Head Trauma Rehabil"},{"key":"1076_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.annemergmed.2011.08.021","volume":"59","author":"L Papa","year":"2012","unstructured":"Papa L, Lewis LM, Falk JL, Zhang Z, Silvestri S, Giordano P, et al. Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann Emerg Med. 2012;59:471\u201383. https:\/\/doi.org\/10.1016\/j.annemergmed.2011.08.021.","journal-title":"Ann Emerg Med."},{"key":"1076_CR31","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1212\/WNL.0b013e318253d5c7","volume":"78","author":"Z Metting","year":"2012","unstructured":"Metting Z, Wilczak N, Rodiger LA, Schaaf JM, van der Naalt J. GFAP and S100B in the acute phase of mild traumatic brain injury. Neurol. 2012;78:1428\u201333. https:\/\/doi.org\/10.1212\/WNL.0b013e318253d5c7.","journal-title":"Neurol."},{"key":"1076_CR32","doi-asserted-by":"publisher","first-page":"830","DOI":"10.4085\/1062-6050-49.3.33","volume":"49","author":"S Schulte","year":"2014","unstructured":"Schulte S, Podlog LW, Hamson-Utley JJ, Strathmann FG, Struder HK. A systematic review of the biomarker s100b: implications for sport-related concussion management. J Athletic Training. 2014;49:830\u201350. https:\/\/doi.org\/10.4085\/1062-6050-49.3.33.","journal-title":"J Athletic Training."},{"key":"1076_CR33","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1177\/0963689717714098","volume":"26","author":"C Devoto","year":"2017","unstructured":"\u2022\u2022 Devoto C, Arcurio L, Fetta J, Ley M, Rodney T, Kanefsky R, et al. Inflammation relates to chronic behavioral and neurological symptoms in military personnel with traumatic brain injuries. Cell Transplant. 2017;26:1169\u201377. https:\/\/doi.org\/10.1177\/0963689717714098Plasma IL-6 and TNF-a were higher in participants with a history of TBI than controls. Within the TBI group, these two biomarkers were higher in those with high compared to low PTSD symptoms.","journal-title":"Cell Transplant"},{"key":"1076_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.psychres.2019.07.001","volume":"279","author":"R Kanefsky","year":"2019","unstructured":"\u2022\u2022 Kanefsky R, Motamedi V, Mithani S, Mysliwiec V, Gill JM, Pattinson CL. Mild traumatic brain injuries with loss of consciousness are associated with increased inflammation and pain in military personnel. Psychiatry Res. 2019;279:34\u20139. https:\/\/doi.org\/10.1016\/j.psychres.2019.07.001Plasma IL-6 (but not TNF-\u03b1 and IL-10) were elevated in participants with history of TBI with LOC compared to participants with TBI without LOC and controls.","journal-title":"Psychiatry Res"},{"key":"1076_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fneur.2019.00246","volume":"10","author":"DK Sandsmark","year":"2019","unstructured":"\u2022\u2022 Sandsmark DK, Bogoslovsky T, Qu BX, Haber M, Cota MR, Davis C, et al. Changes in plasma von willebrand factor and cellular fibronectin in mri-defined traumatic microvascular injury. Front Neurol. 2019;10:246. https:\/\/doi.org\/10.3389\/fneur.2019.00246Plasma vWF was elevated in patients with traumatic hemorrhage but lowest in patients with microvascular injury. cFN levels were higher in the microvascular injury group more than 48 hours post-injury.","journal-title":"Front Neurol"},{"key":"1076_CR36","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1080\/02699052.2018.1471738","volume":"32","author":"J Gill","year":"2018","unstructured":"\u2022\u2022 Gill J, Mustapic M, Diaz-Arrastia R, Lange R, Gulyani S, Diehl T, et al. Higher exosomal tau, amyloid-beta 42 and IL-10 are associated with mild TBIs and chronic symptoms in military personnel. Brain Inj. 2018;32:1277\u201384. https:\/\/doi.org\/10.1080\/02699052.2018.1471738Participants with history of mTBI had elevated neuronal exosomal tau, A\u03b242, and IL-10, with a trend toward the same for A\u03b240. Neuronal exosomal tau correlated with NSI total score and IL-10 correlated with PTSD symptoms.","journal-title":"Brain Inj"},{"key":"1076_CR37","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1089\/neu.2016.4857","volume":"34","author":"V Di Pietro","year":"2017","unstructured":"\u2022\u2022 Di Pietro V, Ragusa M, Davies D, Su Z, Hazeldine J, Lazzarino G, et al. MicroRNAs as novel biomarkers for the diagnosis and prognosis of mild and severe traumatic brain injury. J Neurotrauma. 2017;34:1948\u201356. https:\/\/doi.org\/10.1089\/neu.2016.4857Study investigating up- and down-regulation of miRNAs after TBI, identifying four miRNAs that may be useful for TBI diagnosis and\/or prognosis.","journal-title":"J Neurotrauma"},{"key":"1076_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1089\/neu.2017.5111","volume":"35","author":"SD Hicks","year":"2018","unstructured":"\u2022 Hicks SD, Johnson J, Carney MC, Bramley H, Olympia RP, Loeffert AC, et al. Overlapping microRNA expression in saliva and cerebrospinal fluid accurately identifies pediatric traumatic brain injury. J Neurotrauma. 2018;35:64\u201372. https:\/\/doi.org\/10.1089\/neu.2017.5111Investigated miRNAs from saliva and cerebrospinal fluid following pediatric TBI, idenitfying six miRNAs with parallel changes and ability to identify mild TBI status. This study suggests miRNA from saliva may be a relatively easy and useful biomarker.","journal-title":"J Neurotrauma"},{"key":"1076_CR39","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/neu.2018.6072","volume":"36","author":"L Papa","year":"2019","unstructured":"\u2022\u2022 Papa L, Slobounov SM, Breiter HC, Walter A, Bream T, Seidenberg P, et al. Elevations in microRNA biomarkers in serum are associated with measures of concussion, neurocognitive function, and subconcussive trauma over a single National Collegiate Athletic Association Division I Season in collegiate football players. J Neurotrauma. 2019;36:1343\u201351. https:\/\/doi.org\/10.1089\/neu.2018.6072Assessed miRNAs longitudinally in college football players. Certain miRNAs were associated with concussion assessments at baseline and with cognitive changes over the season.","journal-title":"J Neurotrauma"},{"key":"1076_CR40","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Devoto C, Lai C, Qu BX, Guedes VA, Leete J, Wilde EA, et al. Exosomal MicroRNAs in military persons with mild traumatic brain injury: preliminary results from a chronic effects of neurotrauma consortium (cenc) biomarker discovery project. J Neurotrauma. 2020. https:\/\/doi.org\/10.1089\/neu.2019.6933Investigated miRNA and its relationship with neurobehavioral symptoms. Found altered miRNA regulation following single and repetitive TBIs.","DOI":"10.1089\/neu.2019.6933"},{"key":"1076_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/neu.2015.3881","volume":"33","author":"KKW Wang","year":"2016","unstructured":"Wang KKW, Yang Z, Yue JK, Zhang Z, Winkler EA, Puccio AM, et al. Plasma anti-glial fibrillary acidic protein autoantibody levels during the acute and chronic phases of traumatic brain injury: a transforming research and clinical knowledge in traumatic brain injury pilot study. J Neurotrauma. 2016;33:127\u20131277. https:\/\/doi.org\/10.1089\/neu.2015.3881.","journal-title":"J Neurotrauma."},{"key":"1076_CR42","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1089\/neu.2012.2752","volume":"30","author":"F Tanriverdi","year":"2013","unstructured":"Tanriverdi F, De Bellis A, Ulutabanca H, Bizzarro A, Sinisi AA, Bellastella G, et al. A five year prospective investigation of anterior pituitary function after traumatic brain injury: is hypopituitarism long-term after head trauma associated with autoimmunity? J Neurotrauma. 2013;30:1426\u201333. https:\/\/doi.org\/10.1089\/neu.2012.2752.","journal-title":"J Neurotrauma."},{"key":"1076_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207\u201316. https:\/\/doi.org\/10.1016\/S1474-4422(12)70291-0.","journal-title":"Lancet Neurol"},{"key":"1076_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrneurol.2013.9","volume":"9","author":"H Zetterberg","year":"2013","unstructured":"Zetterberg H, Smith DH, Blennow K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol. 2013;9:201\u201310. https:\/\/doi.org\/10.1038\/nrneurol.2013.9.","journal-title":"Nat Rev Neurol"},{"key":"1076_CR45","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1089\/neu.2014.3548","volume":"32","author":"R Rubenstein","year":"2015","unstructured":"Rubenstein R, Chang B, Davies P, Wagner AK, Robertson CS, Wang KK. A novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids. J Neurotrauma. 2015;32:342\u201352. https:\/\/doi.org\/10.1089\/neu.2014.3548.","journal-title":"J Neurotrauma"},{"key":"1076_CR46","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1001\/jamaneurol.2014.367","volume":"71","author":"P Shahim","year":"2014","unstructured":"Shahim P, Tegner Y, Wilson DH, Randall J, Skillback T, Pazooki D, et al. Blood biomarkers for brain injury in concussed professional ice hockey players. JAMA Neurol. 2014;71:684\u201392. https:\/\/doi.org\/10.1001\/jamaneurol.2014.367.","journal-title":"JAMA Neurol"},{"key":"1076_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-015-1515-z","volume":"131","author":"AC McKee","year":"2016","unstructured":"McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I, et al. The first NINDS\/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016;131:75\u201386. https:\/\/doi.org\/10.1007\/s00401-015-1515-z.","journal-title":"Acta Neuropathol"},{"key":"1076_CR48","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jamaneurol.2017.0655","volume":"74","author":"R Rubenstein","year":"2017","unstructured":"Rubenstein R, Chang B, Yue JK, Chiu A, Winkler EA, Puccio AM, et al. Comparing Plasma Phospho Tau, Total Tau, and Phospho Tau-Total Tau Ratio as Acute and Chronic Traumatic Brain Injury Biomarkers. JAMA Neurol. 2017;74:1063\u201372. https:\/\/doi.org\/10.1001\/jamaneurol.2017.0655.","journal-title":"JAMA Neurol"},{"key":"1076_CR49","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19:422\u201333. https:\/\/doi.org\/10.1016\/S1474-4422(20)30071-5.","journal-title":"Lancet Neurol"},{"key":"1076_CR50","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ar.1091670402","volume":"167","author":"RL Friede","year":"1970","unstructured":"Friede RL, Samorajski T. Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice. Anat Rec. 1970;167:379\u201387. https:\/\/doi.org\/10.1002\/ar.1091670402.","journal-title":"Anat Rec"},{"key":"1076_CR51","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14:577\u201389. https:\/\/doi.org\/10.1038\/s41582-018-0058-z.","journal-title":"Nat Rev Neurol"},{"key":"1076_CR52","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3171\/jns.2003.98.5.1072","volume":"98","author":"DH Smith","year":"2003","unstructured":"Smith DH, Chen XH, Iwata A, Graham DI. Amyloid beta accumulation in axons after traumatic brain injury in humans. J Neurosurg. 2003;98:1072\u20137. https:\/\/doi.org\/10.3171\/jns.2003.98.5.1072.","journal-title":"J Neurosurg."},{"key":"1076_CR53","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/dneu.20774","volume":"70","author":"S Cohen-Cory","year":"2010","unstructured":"Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol. 2010;70:271\u201388. https:\/\/doi.org\/10.1002\/dneu.20774.","journal-title":"Dev Neurobiol."},{"key":"1076_CR54","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/1545968315600525","volume":"30","author":"MD Failla","year":"2016","unstructured":"Failla MD, Juengst SB, Arenth PM, Wagner AK. Preliminary associations between brain-derived neurotrophic factor, memory impairment, functional cognition, and depressive symptoms following severe tbi. Neurorehab Neural Rep. 2016;30:419\u201330. https:\/\/doi.org\/10.1177\/1545968315600525.","journal-title":"Neurorehab Neural Rep."},{"key":"1076_CR55","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1358\/dnp.2007.20.6.1138160","volume":"20","author":"B Gong","year":"2007","unstructured":"Gong B, Leznik E. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders. Drug News Perspect. 2007;20:365\u201370. https:\/\/doi.org\/10.1358\/dnp.2007.20.6.1138160.","journal-title":"Drug News Perspect."},{"key":"1076_CR56","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.brainres.2015.08.031","volume":"2015","author":"GC Brown","year":"1628","unstructured":"Brown GC, Vilalta A. How microglia kill neurons. Brain Res. 1628;2015:288\u201397. https:\/\/doi.org\/10.1016\/j.brainres.2015.08.031.","journal-title":"Brain Res."},{"key":"1076_CR57","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.nurt.2010.07.002","volume":"7","author":"DJ Loane","year":"2010","unstructured":"Loane DJ, Byrnes KR. Role of microglia in neurotrauma. Neurotherapeutics. 2010;7:366\u201377. https:\/\/doi.org\/10.1016\/j.nurt.2010.07.002.","journal-title":"Neurotherapeutics."},{"key":"1076_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","volume":"60","author":"A Varatharaj","year":"2017","unstructured":"Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017;60:1\u201312. https:\/\/doi.org\/10.1016\/j.bbi.2016.03.010.","journal-title":"Brain Behav Immun."},{"key":"1076_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/nedt.1.2.109.61049","volume":"1","author":"F Oosthuizen","year":"2005","unstructured":"Oosthuizen F, Wegener G, Harvey BH. Nitric oxide as inflammatory mediator in post-traumatic stress disorder (PTSD): evidence from an animal model. Neuropsychiatr Dis Treat. 2005;1:109\u201323. https:\/\/doi.org\/10.2147\/nedt.1.2.109.61049.","journal-title":"Neuropsychiatr Dis Treat."},{"key":"1076_CR60","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1101\/lm.037291.114","volume":"22","author":"EJ Kim","year":"2015","unstructured":"Kim EJ, Pellman B, Kim JJ. Stress effects on the hippocampus: a critical review. Learn Mem. 2015;22:411\u20136. https:\/\/doi.org\/10.1101\/lm.037291.114.","journal-title":"Learn Mem."},{"key":"1076_CR61","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","volume":"38","author":"Z Yang","year":"2015","unstructured":"Yang Z, Wang KK. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015;38:364\u201374. https:\/\/doi.org\/10.1016\/j.tins.2015.04.003.","journal-title":"Trends Neurosci."},{"key":"1076_CR62","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/JAD-180325","volume":"67","author":"P Oeckl","year":"2019","unstructured":"Oeckl P, Halbgebauer S, Anderl-Straub S, Steinacker P, Huss AM, Neugebauer H, et al. Glial fibrillary acidic protein in serum is increased in Alzheimer\u2019s disease and correlates with cognitive impairment. J Alzheimers Dis. 2019;67:481\u20138. https:\/\/doi.org\/10.3233\/JAD-180325.","journal-title":"J Alzheimers Dis."},{"key":"1076_CR63","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.expneurol.2015.05.019","volume":"275","author":"K Kenney","year":"2016","unstructured":"Kenney K, Amyot F, Haber M, Pronger A, Bogoslovsky T, Moore C, et al. Cerebral vascular injury in traumatic brain injury. Exper Neurol. 2016;275:353\u201366. https:\/\/doi.org\/10.1016\/j.expneurol.2015.05.019.","journal-title":"Exper Neurol."},{"key":"1076_CR64","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/STROKEAHA.112.653618","volume":"44","author":"GJ Del Zoppo","year":"2013","unstructured":"Del Zoppo GJ. Toward the neurovascular unit. A journey in clinical translation: 2012 Thomas Willis Lecture. Stroke. 2013;44:263\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.112.653618.","journal-title":"Stroke."},{"key":"1076_CR65","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neuron.2019.06.002","volume":"103","author":"DK Sandsmark","year":"2019","unstructured":"Sandsmark DK, Bashir A, Wellington CL, Diaz-Arrastia R. Cerebral microvascular injury: a potentially treatable endophenotype of traumatic brain injury-induced neurodegeneration. Neuron. 2019;103:367\u201379. https:\/\/doi.org\/10.1016\/j.neuron.2019.06.002.","journal-title":"Neuron."},{"key":"1076_CR66","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1089\/neu.2013.3213","volume":"31","author":"BL Bartnik-Olson","year":"2014","unstructured":"Bartnik-Olson BL, Holshouser B, Wang H, Grube M, Tong K, Wong V, et al. Impaired neurovascular unit function contributes to persistent symptoms after concussion: a pilot study. J Neurotrauma. 2014;31:1497\u2013506. https:\/\/doi.org\/10.1089\/neu.2013.3213.","journal-title":"J Neurotrauma."},{"key":"1076_CR67","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/00005072-199708000-00009","volume":"56","author":"S Nag","year":"1997","unstructured":"Nag S, Takahashi JL, Kilty DW. Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J Neuropathol Exp Neurol. 1997;56:912\u201321. https:\/\/doi.org\/10.1097\/00005072-199708000-00009.","journal-title":"J Neuropathol Exp Neurol."},{"key":"1076_CR68","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/00005072-199906000-00006","volume":"58","author":"MA Proescholdt","year":"1999","unstructured":"Proescholdt MA, Heiss JD, Walbridge S, Muhlhauser J, Capogrossi MC, Oldfield EH, et al. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol. 1999;58:613\u201327. https:\/\/doi.org\/10.1097\/00005072-199906000-00006.","journal-title":"J Neuropathol Exp Neurol."},{"key":"1076_CR69","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3109\/02699052.2013.823562","volume":"27","author":"N Muradashvili","year":"2013","unstructured":"Muradashvili N, Lominadze D. Role of fibrinogen in cerebrovascular dysfunction after traumatic brain injury. Brain Inj. 2013;27:1508\u201315. https:\/\/doi.org\/10.3109\/02699052.2013.823562.","journal-title":"Brain Inj."},{"key":"1076_CR70","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1089\/neu.2017.5240","volume":"34","author":"K Sugimoto","year":"2017","unstructured":"Sugimoto K, Suehiro E, Shinoyama M, Sadahiro H, Haji K, Fujiyama Y, et al. D-dimer elevation as a blood biomarker for detection of structural disorder in mild traumatic brain injury. J Neurotrauma. 2017;34:3245\u20138. https:\/\/doi.org\/10.1089\/neu.2017.5240.","journal-title":"J Neurotrauma."},{"key":"1076_CR71","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3233\/JAD-151028","volume":"51","author":"RA Stern","year":"2016","unstructured":"\u2022\u2022 Stern RA, Tripodis Y, Baugh CM, Fritts NG, Martin BM, Chaisson C, et al. Preliminary study of plasma exosomal tau as a potential biomarker for chronic traumatic encephalopathy. J Alzheimers Dis. 2016;51:1099\u2013109. https:\/\/doi.org\/10.3233\/JAD-151028Exosomal tau was related to cognitive performance in retired National Football League players.","journal-title":"J Alzheimers Dis"},{"key":"1076_CR72","doi-asserted-by":"publisher","unstructured":"\u2022 O'Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9. https:\/\/doi.org\/10.3389\/fendo.2018.00402. Review of miRNA, including miRNA biogenesis pathways, dynamics of miRNA action, and mechanisms of miRNA-mediated gene regulations.","DOI":"10.3389\/fendo.2018.00402"},{"key":"1076_CR73","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/jcp.25854","volume":"233","author":"P Paul","year":"2018","unstructured":"\u2022 Paul P, Chakraborty A, Sarkar D, Langthasa M, Rahman M, Bari M, et al. Interplay between miRNAs and human diseases. J Cell Physiol. 2018;233:2007\u201318. https:\/\/doi.org\/10.1002\/jcp.25854Review summarizing how miRNAs play a role in different diseases, as well as their diagnosis and treatment.","journal-title":"J Cell Physiol"},{"key":"1076_CR74","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jneuroim.2006.01.007","volume":"174","author":"AL Cox","year":"2006","unstructured":"Cox AL, Coles AJ, Nortje J, Bradley PG, Chatfield DA, Thompson SJ, et al. An investigation of auto-reactivity after head injury. J Neuroimmunol. 2006;174:180\u20136. https:\/\/doi.org\/10.1016\/j.jneuroim.2006.01.007.","journal-title":"J Neuroimmunol."},{"key":"1076_CR75","doi-asserted-by":"publisher","first-page":"e56805","DOI":"10.1371\/journal.pone.0056805","volume":"8","author":"N Marchi","year":"2013","unstructured":"Marchi N, Bazarian JJ, Puvenna V, Janigro M, Ghosh C, Zhong JH, et al. Consequences of repeated blood-brain barrier disruption in football players. PLOS ONE. 2013;8:e56805. https:\/\/doi.org\/10.1371\/journal.pone.0056805.","journal-title":"PLOS ONE"},{"key":"1076_CR76","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/neu.2014.3736","volume":"32","author":"JE Buonora","year":"2015","unstructured":"Buonora JE, Mousseau M, Jacobowitz DM, Lazarus RC, Yarnell AM, Olsen CH, et al. Autoimmune Profiling Reveals Peroxiredoxin 6 as a Candidate Traumatic Brain Injury Biomarker. J Neurotrauma. 2015;32:185\u20131814. https:\/\/doi.org\/10.1089\/neu.2014.3736.","journal-title":"J Neurotrauma."},{"key":"1076_CR77","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fneur.2018.00072","volume":"9","author":"A Undurti","year":"2018","unstructured":"Undurti A, Colasurdo EA, Sikkema CL, Schultz JS, Peskind ER, Pagulayan KF, et al. Chronic hypopituitarism associated with increased postconcussive symptoms is prevalent after blast-induced mild traumatic brain injury. Front Neurol. 2018;9:72. https:\/\/doi.org\/10.3389\/fneur.2018.00072.","journal-title":"Front Neurol."},{"key":"1076_CR78","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fneur.2015.00068","volume":"6","author":"JE Buonora","year":"2015","unstructured":"Buonora JE, Yarnell AM, Lazarus RC, Mousseau M, Latour LL, Rizoli SB, et al. Multivariate analysis of traumatic brain injury: development of an assessment score. Front Neurol. 2015;6:68. https:\/\/doi.org\/10.3389\/fneur.2015.00068.","journal-title":"Front Neurol."},{"key":"1076_CR79","doi-asserted-by":"publisher","first-page":"e0173798","DOI":"10.1371\/journal.pone.0173798","volume":"12","author":"R Sharma","year":"2017","unstructured":"\u2022\u2022 Sharma R, Rosenberg A, Bennett ER, Laskowitz DT, Acheson SK. A blood-based biomarker panel to risk-stratify mild traumatic brain injury. PLOS ONE. 2017;12:e0173798. https:\/\/doi.org\/10.1371\/journal.pone.0173798Supports use of serum biomarker panels for diagnosis of uncomplicated vs. complicated mild TBI.","journal-title":"PLOS ONE"},{"key":"1076_CR80","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1089\/neu.2019.6375","volume":"36","author":"E Thelin","year":"2019","unstructured":"\u2022\u2022 Thelin E, Al Nimer F, Frostell A, Zetterberg H, Blennow K, Nystrom H, et al. A Serum protein biomarker panel improves outcome prediction in human traumatic brain injury. J Neurotrauma. 2019;36:2850\u201362. https:\/\/doi.org\/10.1089\/neu.2019.6375Systematic review findings that serial sampling of blood biomarkers is impacted by injury characteristics and results in different trajectories that may be helpful in prognosis.","journal-title":"J Neurotrauma"},{"key":"1076_CR81","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1212\/01.wnl.0000120550.00643.dc","volume":"62","author":"PE Vos","year":"2004","unstructured":"Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurol. 2004;62:1303\u201310. https:\/\/doi.org\/10.1212\/01.wnl.0000120550.00643.dc.","journal-title":"Neurol."},{"key":"1076_CR82","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1089\/neu.2011.2127","volume":"29","author":"E Czeiter","year":"2012","unstructured":"Czeiter E, Mondello S, Kovacs N, Sandor J, Gabrielli A, Schmid K, et al. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J Neurotrauma. 2012;29:1770\u20138. https:\/\/doi.org\/10.1089\/neu.2011.2127.","journal-title":"J Neurotrauma."}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-020-01076-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-020-01076-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-020-01076-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:06:54Z","timestamp":1632787614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-020-01076-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,28]]},"references-count":82,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1076"],"URL":"https:\/\/doi.org\/10.1007\/s11910-020-01076-w","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,28]]},"assertion":[{"value":"17 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that there are no conflicts of interest. Dr. Diaz-Arrastia reports that he is a member of the advisory board of and holds stock options in Brain Box Solutions, Inc. and NovaSignal, Inc. He is a consultant for Pinteon Therapeutics, Ischemix, Inc., MesoScale Discoveries, and Quanterix, Inc. The identification of specific products or scientific instrumentation is considered an integral part of the scientific endeavor and does not constitute endorsement or implied endorsement on the part of the author, DoD, or any component agency. The views expressed in this manuscript are those of the authors and do not reflect the official policy of the Department of Army\/Navy\/Air Force, Department of Defense, or U.S. Government.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"54"}}